News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck KGaA (MKGAF.PK) Seeks Investors to Share Clinical Trial Costs


10/14/2013 7:01:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Merck KGaA said it was in talks with private equity firms and other investors to share the cost of some clinical trials, part of the German healthcare group's effort to secure long-term growth. Merck, which is seeking to rebuild a drugs pipeline weakened by a slew of setbacks, is vying with much larger global rivals such as Novartis and Pfizer for licensing deals with biotech research firms. Pharmaceutical companies often team up with each other to share the financial burden of testing drugs, developed either by themselves or biotech firms, on humans.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Financial Times
Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES